Automation of an interferon-γ release assay and comparison to the tuberculin skin test for screening basic military trainees for Mycobacterium tuberculosis infection

Military Medicine

Volumn 179, Issue 3, 2015, Pages 333-341

  Goodwin, Donald J ^a   Mazurek, Gerald H ^b   Campbell, Brandon H ^b   Bohanon, Jamaria ^a   West, Kevin B ^c   Bell, James J ^a   Powell, Richard ^b   Toney, Sean ^b   Morris, John A ^d   Yamane, Grover K ^a   Sjoberg, Paul A ^a  

^a Epidemiology Consult Services US Air Force School of Aerospace Medicine Wright Patterson AFB ^*  (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

^d Diagnostic Division Grifols USA LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADULT; AUTOMATION; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; MALE; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PROCEDURES; RETROSPECTIVE STUDY; SOLDIER; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; AUTOMATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERFERON-GAMMA RELEASE TESTS; MALE; MILITARY PERSONNEL; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES; YOUNG ADULT;

EID: 84924692004     PISSN: 00264075     EISSN: 1930613X     Source Type: Journal    
DOI: 10.7205/MILMED-D-13-00364     Document Type: Article

References (19)

1. Bennett DE, Courval JM, Onorato I et al: Prevalence of tuberculosis infection in the United States population: the National Health and Nutrition Examination Survey, 1999–2000. Am J Respir Crit Care Med 2008; 177: 348–55.
2. Huebner RE, Schein MF, Bass JB Jr: The tuberculin skin test. Clin Infect Dis 1993; 17: 968–75.
3. von Reyn CF, Horsburgh CR, Olivier KN et al: Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacte-rium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5: 1122–8.
4. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A: Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54 (RR-15): 49–55.
5. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P: Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64: 16–22.
6. Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099–1104.
7. Geluk A, van Meijgaarden KE, Franken KL et al: Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis. Infect Immun 2002; 70: 2544–8.
8. Geluk A, van Meijgaarden KE, Franken KL et al: Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis. Scand J Immunol 2004; 59: 66–70.
9. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K: Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep 2010; 59(RR-5): 1–25.
10. Powell RD III, Whitworth WC, Bernardo J, Moonan PK, Mazurek GH: Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests. PLoS One 2011; 6(6): e20061.
11. Cellestis Limited: QuantiFERONÒ-TB Gold In-Tube: Package Insert. Doc. No. US05990301C. October 2007.
12. U.S. Air Force. Air Force Instruction 48-105, Surveillance, Prevention, and Control of Diseases and Conditions of Public Health or Military Significance. March 2005. Available at http://static.e-publishing.af.mil/ production/1/af_ja/publication/afi48-105/afi48-105.pdf; accessed September 9, 2012.
13. American Thoracic Society, Centers for Disease Control and Prevention: Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161: 1376–95.
14. Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000; 49(RR-6): 1–51.
15. World Health Organization: Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2005. Geneva, WHO, 2005 (WHO/ HTM/TB/2005.349).
16. Slater M, Parsonnet J, Banaei N: Investigation of false-positive results given by the QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol 2012; 50: 3105–7.
17. Mazurek GH, Zajdowicz MJ, Hankinson AL et al: Detection of Myco-bacterium tuberculosis infection in United States Navy recruits using the tuberculin skin test or whole-blood interferon-gamma release assays. Clin Infect Dis 2007; 45: 826–36.
18. Mancuso JD, Mazurek GH, Tribble D et al: Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med 2012; 185: 427–34.
19. Mancuso JD, Tribble D, Mazurek GH et al: Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics. Clin Infect Dis 2011; 53: 234–44.